CID 16131945

Rrwcyrkcyrgycyrkcr-nh2

Structural Information

Molecular Formula
C109H164N40O22S4
SMILES
C1[C@H]2C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CSS1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CCCCN)CCCNC(=N)N)CC3=CC=C(C=C3)O)NC(=O)[C@H](CC4=CNC5=CC=CC=C54)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N)CCCCN)CCCNC(=N)N)CC6=CC=C(C=C6)O)CC7=CC=C(C=C7)O)CCCNC(=N)N)CC8=CC=C(C=C8)O
InChI
InChI=1S/C109H164N40O22S4/c110-39-5-3-16-72-93(161)146-82(100(168)135-70(87(113)155)18-8-42-127-105(116)117)54-172-175-57-85(149-99(167)81(51-62-52-132-69-15-2-1-13-67(62)69)145-92(160)74(20-10-44-129-107(120)121)136-88(156)68(112)14-7-41-126-104(114)115)103(171)144-80(50-61-29-37-66(153)38-30-61)98(166)141-76(22-12-46-131-109(124)125)91(159)139-73(17-4-6-40-111)94(162)147-83-55-173-174-56-84(102(170)143-79(49-60-27-35-65(152)36-28-60)97(165)140-75(90(158)138-72)21-11-45-130-108(122)123)148-95(163)77(47-58-23-31-63(150)32-24-58)134-86(154)53-133-89(157)71(19-9-43-128-106(118)119)137-96(164)78(142-101(83)169)48-59-25-33-64(151)34-26-59/h1-2,13,15,23-38,52,68,70-85,132,150-153H,3-12,14,16-22,39-51,53-57,110-112H2,(H2,113,155)(H,133,157)(H,134,154)(H,135,168)(H,136,156)(H,137,164)(H,138,158)(H,139,159)(H,140,165)(H,141,166)(H,142,169)(H,143,170)(H,144,171)(H,145,160)(H,146,161)(H,147,162)(H,148,163)(H,149,167)(H4,114,115,126)(H4,116,117,127)(H4,118,119,128)(H4,120,121,129)(H4,122,123,130)(H4,124,125,131)/t68-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-/m0/s1
InChIKey
OUMZMJXLMONDMD-TUBIBHCQSA-N
Compound name
(1R,4S,7S,10S,13R,18R,21S,24S,27S,30R,33S,39S,42S)-4,21-bis(4-aminobutyl)-N-[(2S)-1-amino-5-carbamimidamido-1-oxopentan-2-yl]-13-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-7,24,39-tris(3-carbamimidamidopropyl)-10,27,33,42-tetrakis[(4-hydroxyphenyl)methyl]-3,6,9,12,20,23,26,29,32,35,38,41,44-tridecaoxo-15,16,46,47-tetrathia-2,5,8,11,19,22,25,28,31,34,37,40,43-tridecazabicyclo[28.14.4]octatetracontane-18-carboxamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

2513.1826 Da
Monoisotopic Mass

-5.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 2514.1899 203.7
[M+Na]+ 2536.1718 201.5
[M-H]- 2512.1753 204.2
[M+NH4]+ 2531.2164 200.8
[M+K]+ 2552.1458 199.0
[M+H-H2O]+ 2496.1799 186.5
[M+HCOO]- 2558.1808 201.3
[M+CH3COO]- 2572.1965 203.4
[M+Na-2H]- 2534.1573 235.0
[M]+ 2513.1821 180.4
[M]- 2513.1831 180.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.